HPV vaccination among gay, bisexual, and other men who have sex with men aged 27–45 years in the United States is potentially Cost-saving
Vaccination of GBMSM through age 45 years is likely a cost-saving use of public health resources.
Authors
- Virginia Senkomago (ORCID: https://orcid.org/0000-0002-9291-8016)
- Donatus U. Ekwueme (ORCID: https://orcid.org/0000-0001-5614-5928)
- Julia Warner Gargano (ORCID: https://orcid.org/0000-0001-9976-178X)
- Lauri Ellen Markowitz (ORCID: https://orcid.org/0000-0002-2480-9520)
- Sameer Vali Gopalani (ORCID: https://orcid.org/0000-0003-0611-305X)
- Harrell W. Chesson (ORCID: https://orcid.org/0000-0002-6695-3141)
- P. A. Clay (ORCID: https://orcid.org/0000-0002-3491-9985)
- Arden Baxter (ORCID: https://orcid.org/0000-0002-6345-2229)
- Carla L. DeSisto (ORCID: https://orcid.org/0000-0001-9065-7070)
- Md Hafizul Islam (ORCID: https://orcid.org/0000-0002-1374-4362)
Institutions
- National Center for Immunization and Respiratory Diseases (US)
- Centers for Disease Control and Prevention (UG)
- National Center for Chronic Disease Prevention and Health Promotion (US)
- National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention (US)
- Centers for Disease Control and Prevention (KE)
Publication Details
- Journal
- Vaccine
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1016/j.vaccine.2025.127798
- Citations
- 1
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 1.35